The North America Emphysema Treatment Market would witness market growth of 5.2% CAGR during the forecast period (2022-2028).
Patients with emphysema may be helped with treatment to alleviate their shortness of breath and reduce the number of times they need to be hospitalized. Before beginning therapy, patients will have a pulmonary function test to see how much air they can blow out. The widespread smoking behavior of a huge percentage of the world's population is the primary driver propelling growth in the emphysema treatment industry. Now, quitting smoking is the treatment that the vast majority of patients choose.
Regarding treating emphysema, bronchodilators, corticosteroids, oxygen medicines, and other antibiotics such as erythromycin are in high demand throughout the world's markets. The development of new medications for the management of emphysema has resulted in enormous profits for the pharmaceutical and medical businesses. There is a significant increase in the number of new products and treatments entering the market, which might restrict worldwide expansion.
According to the Centers for Disease Control and Prevention (CDC), those diagnosed with chronic obstructive pulmonary disease (COPD), including emphysema and chronic bronchitis, have difficulty breathing. Many millions more people suffer with COPD, but the disease has not been identified in their cases, and they are not receiving treatment. In 2019, the number of people living with chronic obstructive pulmonary disease in Canada was 2.0 million (COPD).
In addition, the Centers for Disease Control and Prevention (CDC) reports that about 40 million people in the United States continue to smoke cigarettes. At the same time, 3.08 million middle school and high school kids use at least one tobacco product, particularly electronic cigarettes. About 1,600 children and teenagers in the United States under the age of 18 try their first cigarette daily. About 400,000 people in the United States pass away prematurely due to smoking or exposure to second-hand smoke each year. As a consequence of all of these factors, it is anticipated that the prevalence of emphysema will increase across the countries in the area. Because of this, there is an increased need for the treatment of emphysema in the North American area.
The US market dominated the North America Emphysema Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,967.8 million by 2028. The Canada market is showcasing a CAGR of 7.6% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 6.6% during (2022 - 2028).
Based on Medication Type, the market is segmented into Bronchodilators, Steroids, and Others. Based on Distribution Channel, the market is segmented into Drug Stores & Retail Pharmacies, Hospital Pharmacies, and Online Providers. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Emphysema Treatment Market is Predict to reach $6.05 Billion by 2028, at a CAGR of 6.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AstraZeneca PLC, Teva Pharmaceuticals Industries Ltd., Novartis AG, Viatris, Inc., Orion Corporation, GlaxoSmithKline PLC, Pfizer, Inc., Hikma Pharmaceuticals PLC, Boehringer Ingelheim International GmbH and Verona Pharma Plc.
Scope of the Study
Market Segments Covered in the Report:
By Medication Type
- Bronchodilators
- Steroids
- Others
By Distribution Channel
- Drug Stores & Retail Pharmacies
- Hospital Pharmacies
- Online Providers
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- AstraZeneca PLC
- Teva Pharmaceuticals Industries Ltd.
- Novartis AG
- Viatris, Inc.
- Orion Corporation
- GlaxoSmithKline PLC
- Pfizer, Inc.
- Hikma Pharmaceuticals PLC
- Boehringer Ingelheim International GmbH
- Verona Pharma Plc
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Emphysema Treatment Market, by Medication Type
1.4.2 North America Emphysema Treatment Market, by Distribution Channel
1.4.3 North America Emphysema Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Emphysema Treatment Market
Chapter 4. North America Emphysema Treatment Market by Medication Type
4.1 North America Bronchodilators Market by Country
4.2 North America Steroids Market by Country
4.3 North America Others Market by Country
Chapter 5. North America Emphysema Treatment Market by Distribution Channel
5.1 North America Drug Stores & Retail Pharmacies Market by Country
5.2 North America Hospital Pharmacies Market by Country
5.3 North America Online Providers Market by Country
Chapter 6. North America Emphysema Treatment Market by Country
6.1 US Emphysema Treatment Market
6.1.1 US Emphysema Treatment Market by Medication Type
6.1.2 US Emphysema Treatment Market by Distribution Channel
6.2 Canada Emphysema Treatment Market
6.2.1 Canada Emphysema Treatment Market by Medication Type
6.2.2 Canada Emphysema Treatment Market by Distribution Channel
6.3 Mexico Emphysema Treatment Market
6.3.1 Mexico Emphysema Treatment Market by Medication Type
6.3.2 Mexico Emphysema Treatment Market by Distribution Channel
6.4 Rest of North America Emphysema Treatment Market
6.4.1 Rest of North America Emphysema Treatment Market by Medication Type
6.4.2 Rest of North America Emphysema Treatment Market by Distribution Channel
Chapter 7. Company Profiles
7.1 AstraZeneca PLC
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Approvals and Trials:
7.2 Teva Pharmaceutical Industries Ltd.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Product Launches and Product Expansions:
7.3 Novartis AG
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Approvals and Trials:
7.4 Viatris, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Approvals and Trials:
7.5 Orion Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.6 GlaxoSmithKline PLC
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Product Launches and Product Expansions:
7.6.5.2 Approvals and Trials:
7.7 Pfizer, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional & Segmental Analysis
7.7.4 Research & Development Expense
7.8 Hikma Pharmaceuticals PLC
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expenses
7.9 Boehringer Ingelheim International Gmbh
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional & Segmental Analysis
7.9.4 Research & Development Expenses
7.10. Verona Pharma Plc
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Research & Development Expenses
TABLE 1 North America Emphysema Treatment Market, 2018 - 2021, USD Million
TABLE 2 North America Emphysema Treatment Market, 2022 - 2028, USD Million
TABLE 3 North America Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
TABLE 4 North America Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
TABLE 5 North America Bronchodilators Market by Country, 2018 - 2021, USD Million
TABLE 6 North America Bronchodilators Market by Country, 2022 - 2028, USD Million
TABLE 7 North America Steroids Market by Country, 2018 - 2021, USD Million
TABLE 8 North America Steroids Market by Country, 2022 - 2028, USD Million
TABLE 9 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 10 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 11 North America Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 12 North America Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 13 North America Drug Stores & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 14 North America Drug Stores & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 15 North America Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 16 North America Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 17 North America Online Providers Market by Country, 2018 - 2021, USD Million
TABLE 18 North America Online Providers Market by Country, 2022 - 2028, USD Million
TABLE 19 North America Emphysema Treatment Market by Country, 2018 - 2021, USD Million
TABLE 20 North America Emphysema Treatment Market by Country, 2022 - 2028, USD Million
TABLE 21 US Emphysema Treatment Market, 2018 - 2021, USD Million
TABLE 22 US Emphysema Treatment Market, 2022 - 2028, USD Million
TABLE 23 US Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
TABLE 24 US Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
TABLE 25 US Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 26 US Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 27 Canada Emphysema Treatment Market, 2018 - 2021, USD Million
TABLE 28 Canada Emphysema Treatment Market, 2022 - 2028, USD Million
TABLE 29 Canada Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
TABLE 30 Canada Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
TABLE 31 Canada Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 32 Canada Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 33 Mexico Emphysema Treatment Market, 2018 - 2021, USD Million
TABLE 34 Mexico Emphysema Treatment Market, 2022 - 2028, USD Million
TABLE 35 Mexico Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
TABLE 36 Mexico Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
TABLE 37 Mexico Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 38 Mexico Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 39 Rest of North America Emphysema Treatment Market, 2018 - 2021, USD Million
TABLE 40 Rest of North America Emphysema Treatment Market, 2022 - 2028, USD Million
TABLE 41 Rest of North America Emphysema Treatment Market by Medication Type, 2018 - 2021, USD Million
TABLE 42 Rest of North America Emphysema Treatment Market by Medication Type, 2022 - 2028, USD Million
TABLE 43 Rest of North America Emphysema Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 44 Rest of North America Emphysema Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 45 KEY INFORMATION – AstraZeneca PLC
TABLE 46 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 47 Key Information – Novartis AG
TABLE 48 key information – Viatris, Inc.
TABLE 49 Key Information – Orion Corporation
TABLE 50 Key Information – GlaxoSmithKline PLC
TABLE 51 Key Information – Pfizer, Inc.
TABLE 52 Key Information – Hikma Pharmaceuticals PLC
TABLE 53 Key Information – Boehringer Ingelheim International GmbH
TABLE 54 Key Information – Verona Pharma Plc
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: AstraZeneca Plc